245 related articles for article (PubMed ID: 2497276)
21. Release of natural killer cytotoxic factor (NKCF) from canine natural killer (NK) cells stimulated with cytoplasmic membrane of target cells.
Nakada Y; Tsukatani Y; Kosaka T; Miyamori M; Kuwabara M; Tanaka S; Koide F
J Vet Med Sci; 1995 Feb; 57(1):165-7. PubMed ID: 7756413
[TBL] [Abstract][Full Text] [Related]
22. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
Sibbitt WL; Mathews PM; Bankhurst AD
Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
[TBL] [Abstract][Full Text] [Related]
23. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
Nair MP; Schwartz SA; Menon M
Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
[TBL] [Abstract][Full Text] [Related]
24. Characterization of natural killer cytotoxic factor (NKCF) from canine NK cells.
Nakada Y; Soga M; Kosaka T; Tsukatani Y; Miyamori M; Kuwabara M; Tanaka S; Koide F; Fujiwara K
Vet Immunol Immunopathol; 1996 Jan; 49(4):283-93. PubMed ID: 8677631
[TBL] [Abstract][Full Text] [Related]
25. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
Bonavida B; Wright SC
J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135
[TBL] [Abstract][Full Text] [Related]
26. Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.
Brookes RH; Kew MC; Rabson AR
Cancer Immunol Immunother; 1987; 25(2):149-52. PubMed ID: 2822243
[TBL] [Abstract][Full Text] [Related]
27. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).
Marubayashi M; Solana R; Ramirez R; Aranda E; Galan F; Peña J
Br J Cancer; 1991 Jun; 63(6):893-6. PubMed ID: 1906292
[TBL] [Abstract][Full Text] [Related]
28. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms involved in NK resistance induced by interferon-gamma.
Ramirez R; Solana R; Carracedo J; Alonso MC; Peña J
Cell Immunol; 1992 Mar; 140(1):248-56. PubMed ID: 1739986
[TBL] [Abstract][Full Text] [Related]
30. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
Blanca I; Herberman RB; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671
[TBL] [Abstract][Full Text] [Related]
31. YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.
Wright SC; Bonavida B
Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1688-92. PubMed ID: 6572932
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
[TBL] [Abstract][Full Text] [Related]
33. Analysis of rat natural killer cytotoxic factor (NKCF): mechanism of action and relationship to other cytotoxic/cytostatic factors.
Winkler-Pickett RT; Young HA; Kuta A; Ortaldo JR
Cell Immunol; 1991 Jun; 135(1):42-54. PubMed ID: 2018982
[TBL] [Abstract][Full Text] [Related]
34. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
Scott-Algara D; Vuillier F; Cayota A; Dighiero G
Clin Exp Immunol; 1992 Nov; 90(2):181-7. PubMed ID: 1424272
[TBL] [Abstract][Full Text] [Related]
35. Human natural killer cytotoxic factor (NKCF): role of IFN-alpha.
Steinhauer EH; Doyle AT; Kadish AS
J Immunol; 1985 Jul; 135(1):294-9. PubMed ID: 3998466
[TBL] [Abstract][Full Text] [Related]
36. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic factor produced by human blood lymphocytes of low density upon exposure to autologous B cells.
Saranath D; Masucci MG; Klein E
Immunol Lett; 1986 Mar; 12(2-3):141-6. PubMed ID: 3013760
[TBL] [Abstract][Full Text] [Related]
38. Impaired release of natural killer cytotoxic factor(s) by peripheral blood lymphocytes in patients with chronic LGL-proliferative disease.
Eliopoulos GD; Vaiopoulos G; Kyriakou D; Eliopoulos AG; Papadaki H; Katrinakis G; Alexandrakis M
Haematologica; 1993; 78(4):219-24. PubMed ID: 8294053
[TBL] [Abstract][Full Text] [Related]
39. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
Wright SC; Wilbur SM; Bonavida B
Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
[TBL] [Abstract][Full Text] [Related]
40. A killing defect of natural killer cells with the absence of natural killer cytotoxic factors in a child with Hodgkin's disease.
Komiyama A; Kawai H; Yamada S; Kato M; Yanagisawa M; Miyagawa Y; Akabane T
Blood; 1987 Jun; 69(6):1686-90. PubMed ID: 3580573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
